Osaic Holdings Inc. Raises Stock Position in GE HealthCare Technologies Inc. $GEHC

Osaic Holdings Inc. grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 18.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 224,869 shares of the company’s stock after acquiring an additional 34,499 shares during the period. Osaic Holdings Inc.’s holdings in GE HealthCare Technologies were worth $16,674,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Orion Porfolio Solutions LLC raised its position in GE HealthCare Technologies by 13.0% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 78,061 shares of the company’s stock valued at $5,782,000 after purchasing an additional 8,959 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in shares of GE HealthCare Technologies by 229.3% during the second quarter. Thrivent Financial for Lutherans now owns 71,233 shares of the company’s stock valued at $5,277,000 after buying an additional 49,601 shares during the period. State of Wyoming raised its holdings in shares of GE HealthCare Technologies by 21.7% in the second quarter. State of Wyoming now owns 4,955 shares of the company’s stock valued at $367,000 after acquiring an additional 885 shares in the last quarter. Old North State Trust LLC purchased a new stake in GE HealthCare Technologies in the second quarter worth about $271,000. Finally, N.E.W. Advisory Services LLC grew its holdings in GE HealthCare Technologies by 75.2% during the 2nd quarter. N.E.W. Advisory Services LLC now owns 545 shares of the company’s stock worth $40,000 after acquiring an additional 234 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. BTIG Research reaffirmed a “buy” rating and issued a $87.00 price target on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Stifel Nicolaus set a $90.00 target price on GE HealthCare Technologies in a report on Friday, November 21st. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Finally, Morgan Stanley raised their price objective on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research report on Thursday, October 30th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $87.09.

Check Out Our Latest Analysis on GEHC

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $82.52 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a fifty day moving average price of $77.45 and a 200-day moving average price of $75.30. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The firm has a market cap of $37.59 billion, a PE ratio of 17.05, a P/E/G ratio of 3.44 and a beta of 1.10.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last announced its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same period in the previous year, the business earned $1.14 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Further Reading

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.